“…There is evidence that in several conditions, inflammation augments oxidative stress and vice-versa, whereas such interrelation has also been implicated in the pathophysiology of AF [12,13,17]. Two recent studies showed that statin therapy was associated with a significant decrease in AF recurrence after successful cardioversion and a reduced incidence of AF in coronary artery disease patients, raising the possibility of a favourable action in atrial remodeling through anti-inflammatory and antioxidant action [20][21][22]. Very recently, Dernellis and Panaretou in a placebocontrolled trial showed that methylpredisolone administration significantly reduced the recurrence rate of AF as well as the plasma CRP levels in patients with a first shortduration episode of persistent AF [23].…”